NHT
IDXX icon

New Hampshire Trust’s Idexx Laboratories IDXX Stock Holding History

New Hampshire Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52M Buy
6,694
+12
+0.2% +$6.73K 0.66% 43
2026
Q1 		$3.75M Sell
6,682
-38
-0.6% -$24.4K 0.76% 42
2025
Q4 		$4.55M Sell
6,720
-1
-0% -$681 0.88% 32
2025
Q3 		$4.29M Buy
6,721
+283
+4% +$172K 0.83% 34
2025
Q2 		$3.45M Sell
6,438
-75
-1% -$35.9K 0.72% 38
2025
Q1 		$2.74M Hold
6,513
– – 0.63% 49
2024
Q4 		$2.69M Sell
6,513
-30
-0.5% -$13.2K 0.57% 53
2024
Q3 		$3.31M Hold
6,543
– – 0.71% 43
2024
Q2 		$3.19M Sell
6,543
-190
-3% -$95.4K 0.73% 42
2024
Q1 		$3.64M Sell
6,733
-216
-3% -$118K 0.85% 38
2023
Q4 		$3.86M Hold
6,949
– – 0.93% 29
2023
Q3 		$3.04M Hold
6,949
– – 0.83% 37
2023
Q2 		$3.49M Sell
6,949
-86
-1% -$41.2K 0.91% 28
2023
Q1 		$3.52M Sell
7,035
-17
-0.2% -$8.13K 0.94% 28
2022
Q4 		$2.88M Buy
+7,052
New +$2.74M 0.76% 36

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

New Hampshire Trust's IDXX Position: Q2 2026 in Review

New Hampshire Trust increased its Idexx Laboratories (IDXX) stake by 0.18% in Q2 2026, buying an estimated $6.73K and bringing the position to 6,694 shares worth $3.52M. The position accounts for 0.66% of the portfolio, ranked #43.

New Hampshire Trust first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.55M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • New Hampshire Trust held 6,694 shares of Idexx Laboratories worth $3.52M as of Q2 2026.
  • New Hampshire Trust bought 12 Idexx Laboratories shares in Q2 2026, an estimated $6.73K.
  • Idexx Laboratories made up 0.66% of New Hampshire Trust's portfolio in Q2 2026, its #43 holding.
  • New Hampshire Trust first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • New Hampshire Trust's Idexx Laboratories position peaked at $4.55M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.